在急性心肌梗塞后左心室重塑的最佳定义和预测名图
Sicheng Zhang1,2,3,4, Zheng Zhu5, Manqing Luo1,2,3,4
1Department of Cardiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.
ESC heart failure
|July 25, 2023
概括
在心肌梗塞后的左心室重塑预示着不良结果. 通过左心室喷射分数 (LVEF) 定义重塑对于预测死亡率至关重要,新的名谱有助于识别有风险的患者.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 医学诊断 医学诊断 医学诊断
背景情况:
- 急性心肌梗塞 (AMI) 后的左心室 (LV) 重塑与心力衰竭和死亡率有关.
- 在LV改造定义上缺乏共识,阻碍了预后评估.
- 之前的研究没有比较不同LV改造定义的预后价值.
研究的目的:
- 为了确定AMI后LV改造的最佳定义.
- 开发一种预测性名谱,用于识别患有LV重塑风险的患者.
- 创建一个在线计算器来评估LV改造风险.
主要方法:
- 对829名接受穿皮冠状动脉干预的AMI患者进行前性观察研究.
- 在入院时进行心声扫描,并在6个月后评估LV重塑 (定义为LVEDV,LVESV或LVEF).
- 拉索和多变量逻辑回归用于名图开发;AUC,校准和决策曲线分析用于验证.
主要成果:
- LV 重塑的发生率为24.85% (LVEDV),28.71% (LVESV) 和14.60% (LVEF).
- 所有定义独立地预测了复合终点,但只有LVEF定义的改造预测了所有原因的死亡率 (HR 2.78).
- 一个7个变量名图 (包括BP,HR,AMI类型,支架长度,NT-proBNP,troponin I,葡萄糖) 显示出良好的预测性能 (AUC 0.766).
结论:
- 根据各种定义,LV重塑预测PCI后AMI患者的长期不良结果.
- 左心室喷射率 (LVEF) <50%是预测所有原因死亡率的最合适的定义.
- 开发的诺米图提供了一个准确和有效的工具,用于预测心脏病发作后的LV重塑.
更多相关视频
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11


